Robotic surgery for gastrointestinal malignancies

C. Anderson, M. Hellan, K. Kernstine, J. Ellenhorn, L. Lai, V. Trisal, A. Pigazzi

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: This report describes our initial experience with the use of robotic-assisted surgery for the treatment of gastrointestinal (GI) malignancies. Methods: Between November 2004 and July 2007, 73 robotic procedures (26 female, 47 male) for GI cancer were performed and retrospectively reviewed. Procedures included 25 oesophagectomies, 11 gastrectomies and 37 rectal resections. The median body mass index (BMI) for this patient population was 26. Results: The median operative times for rectal, oesophageal and gastric resections were 285, 482 and 430 min, respectively. There were three conversions. Major postoperative morbidity was 16% for rectal, 32% for oesophageal and 9% for gastric procedures. The leak rate was 11% for rectal, 16% for oesophageal and 9% for gastric anastomoses. Median length of stay was 4, 11 and 5 days, respectively. The median number of lymph nodes harvested was 13, 22, and 26 for rectal, oesophageal and gastric lymphadenectomies, respectively. At a median follow-up of 9 months, one patient developed a port site recurrence; 30 day mortality was zero. Conclusion: This initial experience suggests that the robotic approach is safe and feasible for a variety of radical oncological surgical procedures.

Original languageEnglish (US)
Pages (from-to)297-300
Number of pages4
JournalInternational Journal of Medical Robotics and Computer Assisted Surgery
Volume3
Issue number4
DOIs
StatePublished - Dec 2007

Fingerprint

Robotics
Stomach
Neoplasms
Surgery
Gastrointestinal Neoplasms
Esophagectomy
Gastrectomy
Operative Time
Lymph Node Excision
Length of Stay
Body Mass Index
Lymph Nodes
Robotic surgery
Morbidity
Recurrence
Mortality
Population

Keywords

  • Esophageal cancer
  • Gastric cancer
  • Gastrointestinal malignancies
  • Rectal cancer
  • Robotics

ASJC Scopus subject areas

  • Computer Science Applications
  • Biophysics
  • Surgery
  • Medicine(all)

Cite this

Robotic surgery for gastrointestinal malignancies. / Anderson, C.; Hellan, M.; Kernstine, K.; Ellenhorn, J.; Lai, L.; Trisal, V.; Pigazzi, A.

In: International Journal of Medical Robotics and Computer Assisted Surgery, Vol. 3, No. 4, 12.2007, p. 297-300.

Research output: Contribution to journalArticle

Anderson, C. ; Hellan, M. ; Kernstine, K. ; Ellenhorn, J. ; Lai, L. ; Trisal, V. ; Pigazzi, A. / Robotic surgery for gastrointestinal malignancies. In: International Journal of Medical Robotics and Computer Assisted Surgery. 2007 ; Vol. 3, No. 4. pp. 297-300.
@article{b6fa0a4accfb4e7f8b0af6f054360597,
title = "Robotic surgery for gastrointestinal malignancies",
abstract = "Background: This report describes our initial experience with the use of robotic-assisted surgery for the treatment of gastrointestinal (GI) malignancies. Methods: Between November 2004 and July 2007, 73 robotic procedures (26 female, 47 male) for GI cancer were performed and retrospectively reviewed. Procedures included 25 oesophagectomies, 11 gastrectomies and 37 rectal resections. The median body mass index (BMI) for this patient population was 26. Results: The median operative times for rectal, oesophageal and gastric resections were 285, 482 and 430 min, respectively. There were three conversions. Major postoperative morbidity was 16{\%} for rectal, 32{\%} for oesophageal and 9{\%} for gastric procedures. The leak rate was 11{\%} for rectal, 16{\%} for oesophageal and 9{\%} for gastric anastomoses. Median length of stay was 4, 11 and 5 days, respectively. The median number of lymph nodes harvested was 13, 22, and 26 for rectal, oesophageal and gastric lymphadenectomies, respectively. At a median follow-up of 9 months, one patient developed a port site recurrence; 30 day mortality was zero. Conclusion: This initial experience suggests that the robotic approach is safe and feasible for a variety of radical oncological surgical procedures.",
keywords = "Esophageal cancer, Gastric cancer, Gastrointestinal malignancies, Rectal cancer, Robotics",
author = "C. Anderson and M. Hellan and K. Kernstine and J. Ellenhorn and L. Lai and V. Trisal and A. Pigazzi",
year = "2007",
month = "12",
doi = "10.1002/rcs.155",
language = "English (US)",
volume = "3",
pages = "297--300",
journal = "International Journal of Medical Robotics and Computer Assisted Surgery",
issn = "1478-596X",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Robotic surgery for gastrointestinal malignancies

AU - Anderson, C.

AU - Hellan, M.

AU - Kernstine, K.

AU - Ellenhorn, J.

AU - Lai, L.

AU - Trisal, V.

AU - Pigazzi, A.

PY - 2007/12

Y1 - 2007/12

N2 - Background: This report describes our initial experience with the use of robotic-assisted surgery for the treatment of gastrointestinal (GI) malignancies. Methods: Between November 2004 and July 2007, 73 robotic procedures (26 female, 47 male) for GI cancer were performed and retrospectively reviewed. Procedures included 25 oesophagectomies, 11 gastrectomies and 37 rectal resections. The median body mass index (BMI) for this patient population was 26. Results: The median operative times for rectal, oesophageal and gastric resections were 285, 482 and 430 min, respectively. There were three conversions. Major postoperative morbidity was 16% for rectal, 32% for oesophageal and 9% for gastric procedures. The leak rate was 11% for rectal, 16% for oesophageal and 9% for gastric anastomoses. Median length of stay was 4, 11 and 5 days, respectively. The median number of lymph nodes harvested was 13, 22, and 26 for rectal, oesophageal and gastric lymphadenectomies, respectively. At a median follow-up of 9 months, one patient developed a port site recurrence; 30 day mortality was zero. Conclusion: This initial experience suggests that the robotic approach is safe and feasible for a variety of radical oncological surgical procedures.

AB - Background: This report describes our initial experience with the use of robotic-assisted surgery for the treatment of gastrointestinal (GI) malignancies. Methods: Between November 2004 and July 2007, 73 robotic procedures (26 female, 47 male) for GI cancer were performed and retrospectively reviewed. Procedures included 25 oesophagectomies, 11 gastrectomies and 37 rectal resections. The median body mass index (BMI) for this patient population was 26. Results: The median operative times for rectal, oesophageal and gastric resections were 285, 482 and 430 min, respectively. There were three conversions. Major postoperative morbidity was 16% for rectal, 32% for oesophageal and 9% for gastric procedures. The leak rate was 11% for rectal, 16% for oesophageal and 9% for gastric anastomoses. Median length of stay was 4, 11 and 5 days, respectively. The median number of lymph nodes harvested was 13, 22, and 26 for rectal, oesophageal and gastric lymphadenectomies, respectively. At a median follow-up of 9 months, one patient developed a port site recurrence; 30 day mortality was zero. Conclusion: This initial experience suggests that the robotic approach is safe and feasible for a variety of radical oncological surgical procedures.

KW - Esophageal cancer

KW - Gastric cancer

KW - Gastrointestinal malignancies

KW - Rectal cancer

KW - Robotics

UR - http://www.scopus.com/inward/record.url?scp=38949183040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949183040&partnerID=8YFLogxK

U2 - 10.1002/rcs.155

DO - 10.1002/rcs.155

M3 - Article

C2 - 17948920

AN - SCOPUS:38949183040

VL - 3

SP - 297

EP - 300

JO - International Journal of Medical Robotics and Computer Assisted Surgery

JF - International Journal of Medical Robotics and Computer Assisted Surgery

SN - 1478-596X

IS - 4

ER -